Background
Dry Eye Disease
Our Solution
Leadership Team
Contact Us
Menu
Background
Dry Eye Disease
Our Solution
Leadership Team
Contact Us
Facebook
Linkedin
Press Releases
TearSolutions, Inc. Appoints Leonard Borrmann To Its Board of Directors
View More
Middleland Capital’s VTC Innovation Fund and Pharmstandard International Co-lead $8.5m Series B Financing of TearSolutions, Inc.
View More
TearSolutions, Inc. Announces Results from Phase I/II trial of Lacripep TM to Treat Primary Sjögren’s Syndrome and Appoints Anil Asrani President and CEO
View More
TearSolutions Raises $3M Series A Round to Advance The Treatment of Dry Eye
View More
TearSolutions, Inc., Announces Results From First-In-Human Clinical Trial published in Cornea
View More